Direkt zum Inhalt
Merck

H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores.

Clinical toxicology (Philadelphia, Pa.) (2015-05-13)
Takashi Sonobe, Philippe Haouzi
ZUSAMMENFASSUNG

Hydrogen sulfide (H2S) intoxication produces an acute depression in cardiac contractility-induced circulatory failure, which has been shown to be one of the major contributors to the lethality of H2S intoxication or to the neurological sequelae in surviving animals. Methylene blue (MB), a phenothiazinium dye, can antagonize the effects of the inhibition of mitochondrial electron transport chain, a major effect of H2S toxicity. We investigated whether MB could affect the immediate outcome of H2S-induced coma in un-anesthetized animals. Second, we sought to characterize the acute cardiovascular effects of MB and two of its demethylated metabolites-azure B and thionine-in anesthetized rats during lethal infusion of H2S. First, MB (4 mg/kg, intravenous [IV]) was administered in non-sedated rats during the phase of agonal breathing, following NaHS (20 mg/kg, IP)-induced coma. Second, in 4 groups of urethane-anesthetized rats, NaHS was infused at a rate lethal within 10 min (0.8 mg/min, IV). Whenever cardiac output (CO) reached 40% of its baseline volume, MB, azure B, thionine, or saline were injected, while sulfide infusion was maintained until cardiac arrest occurred. Seventy-five percent of the comatose rats that received saline (n = 8) died within 7 min, while all the 7 rats that were given MB survived (p = 0.007). In the anesthetized rats, arterial, left ventricular pressures and CO decreased during NaHS infusion, leading to a pulseless electrical activity within 530 s. MB produced a significant increase in CO and dP/dtmax for about 2 min. A similar effect was produced when MB was also injected in the pre-mortem phase of sulfide exposure, significantly increasing survival time. Azure B produced an even larger increase in blood pressure than MB, while thionine had no effect. MB can counteract NaHS-induced acute cardiogenic shock; this effect is also produced by azure B, but not by thionine, suggesting that the presence of methyl groups is a prerequisite for producing this protective effect.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Salzsäure -Lösung, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Salzsäure, 36.5-38.0%, BioReagent, for molecular biology
Supelco
Salzsäure -Lösung, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Chlorwasserstoff, ReagentPlus®, ≥99%
Sigma-Aldrich
Schwefelwasserstoff, ≥99.5%
Sigma-Aldrich
Schwefelwasserstoff -Lösung, 0.8 M in THF
Sigma-Aldrich
Salzsäure -Lösung, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Chlorwasserstoff -Lösung, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Salzsäure -Lösung, 32 wt. % in H2O, FCC
Sigma-Aldrich
Azure B, certified by the Biological Stain Commission
Sigma-Aldrich
Azure B, prepared by direct synthesis
Sigma-Aldrich
Bromobiman, suitable for fluorescence, BioReagent, ≥95% (HPCE)
Sigma-Aldrich
Bromobiman, ≥97% (HPLC)
Sigma-Aldrich
Schwefel-32S, 99.9 atom % 32S